The dosage market size value per capita for Penicillins and Streptomycins in Slovakia has observed a declining trend from 2013 to 2023. In 2023, this value stood at $2.78. A notable decreasing pattern can be identified with particular drops between 2015 and 2017. Over the last two years, the market saw a year-on-year reduction, while the compound annual growth rate (CAGR) over the past five years reflects an average yearly decline.

For future trends to watch for:

Monitor shifts in prescription policies and antibiotic resistance impacts.
Watch for potential health policy changes affecting market dynamics.
Investigate technological advancements in alternative treatments influencing demand.